Cost effectiveness of a community based research project to help women quit smoking.
OBJECTIVE
To estimate the cost effectiveness of a four year, multifaceted, community based research project shown previously to help women quit smoking.


METHODS
A quasi-experimental matched control design.


METHODS
Two counties in Vermont and two in New Hampshire, USA.


METHODS
Women aged 18-64 years.


METHODS
Costs were the grant related expenditures converted to 2002 US dollars. Survey results at the end of the intervention were used to estimate the numbers of never smokers, former smokers, light smokers, and heavy smokers in the intervention and comparison counties, and 1986 life tables for populations of US women categorised by smoking status to estimate the gain in life expectancy.


METHODS
Cost effectiveness ratios, as dollars per life-year saved, for the intervention only and for total grant costs (intervention, evaluation and indirect costs).


RESULTS
The cost effectiveness ratio for the intervention, in 2002 US dollars per life-year saved, discounted at 3%, was 1156 dollars (90% confidence interval (CI) 567 dollars to infinity), and for the total grant, 4022 dollars (90% CI 1973 dollars to infinity). When discounted at 5%, these ratios were 1922 dollars (90% CI 1024 dollars to 15,647 dollars), and 6683 dollars (90% CI 3555 dollars to 54,422 dollars), respectively.


CONCLUSIONS
The cost effectiveness ratios of this research project are economically attractive, and are comparable with other smoking cessation interventions for women. These observations should encourage further research and dissemination of community based interventions to reduce smoking.
Secker-Walker
R H
RH
The Office of Health Promotion Research, University of Vermont, Burlington, Vermont, USA. roger.secker-walker@.uvm.edu
Holland
R R
RR
Lloyd
C M
CM
Pelkey
D
D
Flynn
B S
BS
D000293:Adolescent; D000328:Adult; D016022:Case-Control Studies; D015331:Cohort Studies; D003362:Cost-Benefit Analysis / Q000191:economics; D005260:Female; D006801:Humans; D008017:Life Expectancy; D008875:Middle Aged; D009513:New Hampshire; D019057:Quality-Adjusted Life Years; D012106:Research / Q000191:economics; D012107:Research Design; D016540:Smoking Cessation / Q000191:economics*; D014707:Vermont
Am J Public Health. 1999 Dec;89(12):1819-26
10589309
BMJ. 1998 Feb 28;316(7132):705
9522813
Am J Public Health. 2000 Jun;90(6):940-6
10846513
Prev Med. 2001 Feb;32(2):118-27
11162337
Health Promot Int. 2002 Mar;17(1):43-50
11847137
Cochrane Database Syst Rev. 2002;(3):CD001745
12137631
Med Care. 1982 Jul;20(7):663-75
6811807
Annu Rev Public Health. 1985;6:147-93
3873246
Annu Rev Public Health. 1985;6:41-63
2859868
Med Care. 1986 Aug;24(8):767-80
3090379
JAMA. 1986 Sep 12;256(10):1315-8
3091857
Am J Public Health. 1987 Feb;77(2):162-5
3099586
JAMA. 1989 Jan 6;261(1):75-9
2491762
BMJ. 1991 May 11;302(6785):1119-22
1904286
Soc Sci Med. 1991;32(10):1151-9
2068598
J Epidemiol Community Health. 1993 Jun;47(3):215-23
8350035
Health Policy. 1993 Nov;26(1):43-53
10130845
Int J Technol Assess Health Care. 1994 Spring;10(2):317-24
8034412
Prev Med. 1994 Nov;23(6):800-8
7855113
Am J Public Health. 1995 Feb;85(2):193-200
7856778
Clin Ther. 1995 Jan-Feb;17(1):109-25
7758053
JAMA. 1996 Apr 24;275(16):1247-51
8601956
J Clin Epidemiol. 1996 Apr;49(4):435-9
8621994
BMJ. 1996 May 18;312(7041):1274-8
8634618
J Epidemiol Community Health. 1996 Apr;50(2):190-5
8762387
Am J Prev Med. 1996 Sep-Oct;12(5):367-77
8909648
Prev Med. 1996 Nov-Dec;25(6):708-16
8936573
Am J Prev Med. 1997 Jan-Feb;13(1):18-25
9037338
Women Health. 1997;25(1):23-35
9253136
BMJ. 1997 Sep 6;315(7108):582-5
9302957
JAMA. 1997 Dec 3;278(21):1759-66
9388153
Prev Med. 2000 Feb;30(2):126-37
10656840